carbostyril has been researched along with Somatoform Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antell, MH; Bourque, B; Diloreto, S; Heo, S; Rotolo, SM; Safirstein, J; Young, DC | 1 |
| Amano, N; Hanihara, T; Takahashi, T; Takahashi, Y; Washizuka, S; Yasaki, T | 1 |
| Fukui, K; Nagoshi, Y; Tominaga, T | 1 |
| Wagner, KD | 1 |
4 other study(ies) available for carbostyril and Somatoform Disorders
| Article | Year |
|---|---|
Mental status changes during elexacaftor/tezacaftor / ivacaftor therapy.
Topics: Affect; Aminophenols; Benzodioxoles; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Humans; Indoles; Mental Fatigue; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Somatoform Disorders | 2022 |
Cavum septum pellucidum and cavum vergae with late-onset catatonia.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Brain; Catatonia; Cysteine; Electroconvulsive Therapy; Female; Humans; Hypnotics and Sedatives; Lorazepam; Magnetic Resonance Imaging; Organotechnetium Compounds; Piperazines; Quinolones; Radiopharmaceuticals; Septum Pellucidum; Somatoform Disorders; Tomography, Emission-Computed, Single-Photon | 2013 |
Effect of aripiprazole augmentation for treatment-resistant somatoform disorder: a case series.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Female; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome | 2014 |
Life events, medical comorbidity, and somatic symptoms in pediatric mood disorders.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Comorbidity; Female; Humans; Hungary; Life Change Events; Male; Mood Disorders; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Somatoform Disorders; United States | 2009 |